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Intestinal flora
Immediately after birth the intestines
of infants are totally sterile and do not
contain any bacteria, not even ‘good’
bacteria. During the natural birth
process, the infant receives some
beneficial bacteria from the mother.
This gift of organisms immediately
starts to multiply in the tiny gastro-
intestinal (GI) tract of the infant and
boosts its immunity. Bifidobacteria
infantis is the dominant bacteria in the
infant’s digestive tract. These bacteria
decrease the growth of so-called rota-
viruses which cause diarrhoea and
thrush, thus protecting the newborn
infant against common infections. The
bifidobacteria also help to prevent
lactose intolerance and increase the
absorption of minerals and B vitamins,
and boost the infant’s immature
immune system. Breastfeeding is an
excellent way of increasing the
number of bifidobacteria in the infant’s
GI tract.2, 3
Infant formula has also been
supplemented with these beneficial
bacteria in the form of bifidobacterium
and lactobacilli called probiotics to
enhance this response in non-
breastfed infants. These probiotics or
cultures of beneficial bacteria compete
with harmful bacteria in the GI tract
for food and prevent the transport of
pathogens into the body. Probiotics
also increase the uptake of important
minerals from the GI tract, thus
preventing deficiencies which can also
lower immunity.2 As humans get older,
they develop a deficiency of beneficial
bacteria and therefore become more
vulnerable to infections.
LCPUFAs
Human breast milk is also rich in
long-chain polyunsaturated fatty
acids (LCPUFA),  which have
i m m u n o m o d u l a t o r y  a c t i o n s .
Probiotics and LCPUFAs together
modulate T-helper 1 and 2 responses,
show antibiotic-like actions, and
alleviate changes related to allergic
inflammation. LCPUFAs promote the
adhesion of probiotics to mucosal
surfaces, which augment the health-
promoting effects of probiotics. In
view of the similarity in their actions
and because LCPUFAs promote the
actions of probiotics, a combination
of LCPUFAs and probiotics offers
significant protection. It is likely that
breastfeeding and probiotics are two
naturally occurring, appropriate
events in early human life that have
significant health benefits.4 In a study
by Duchen et al, mothers whose
children were found to be allergic
were shown to have lower levels of
long chain polyunsaturated fatty
acids in their breast milk compared
to the milk of non allergic children. It
has been recommended that infant
formula for term infants should
contain at least 0.2% of total
polyunsaturated fatty acids as
docosahexaenoic acid (DHA) and
0.35% as arachidonic acid (AA). The
highly unsaturated nature of DHA,
with 6 double bonds, makes it
particularly susceptible to lipid
peroxidation. Because the generation
of damaging free radicals is
associated with extensive lipid
peroxidation, there is some concern
regarding the safe use of long chain
polyunsaturated fatty acids in infant
Introduction
The intestine is the largest organ in the immune system of the body, and as such is the location for the majority of
lymphocytes and other immune effector cells. The intestine is exposed to vast quantities of dietary and microbial foreign
bodies (pathogens), which, in some instances, are potentially lethal. The development of normal immune function of
the intestine is therefore vital for survival, and is dependent on appropriate antigen exposure and processing, and an
intact intestinal barrier. In early life, maternal colostrums and milk can significantly augment resistance to enteric infections.
The mechanisms of enhancing disease resistance are thought to be passive, involving a direct support of anti-microbial
factors, and active, by promoting the development of specific immune functions. A tolerance response to dietary and
non-invasive antigens is generally induced in the gut. However, it must also be able to mount an adequate immune
response to ensure clearance of foreign antigens. Regulation of tolerance and active immune responses are critical to
health, and failure to regulate these responses can lead to recurrent infections, inflammatory diseases and allergies.
The education of the immune system in early life is thought to be critical in minimising the occurrence of these immune-
based disorders.1                (SA Fam Pract 2005;47(5): 56-58)
SA Fam Pract 2005;47(5)66
Review
formula.5, 6 However, the benefits may
outweigh these safety concerns.
Cytokines and lymphocytes
Cytokines and lymphocytes present
in breast milk can influence the
development of the immune system.
This suggests an immunoregulatory
role for breast milk that is absent in
infants consuming formula. A study
by Hawkes et al was conducted to
investigate the potential difference in
lymphocyte subsets between breast-
fed and formula-fed infants at 6 months
of age. The frequency of natural killer
(NK) cells (CD3-/CD16+ +CD56+) was
greater in breast-fed infants (9,2%)
than in formula-fed infants (6,6%,
p<0.001), while the CD4 to CD8 ratio
was 2.8 in breast-fed infants compared
with 3.4 in formula-fed infants
(P<0.001). Therefore breast-fed infants
(<250ml formula/ breast milk per week)
had a greater proportion of NK cells
and a lower CD4 to CD8 ratio than
formula-fed infants at 6 months of age.7
Nucleotides
The immunoprotective benefits of
human milk, the biology of human
m i l k  n u c l e o t i d e s  a n d  t h e
immunological and gastrointestinal
effects of dietary nucleotides have
also been investigated. Several
animal studies by Yu,8,9 animal studies
have shown that dietary nucleotides
enhance a number of immune
responses,  and the  growth ,
differentiation and repair of the gut.
Several clinical studies have reported
beneficial effects of nucleotide
supplementation on gut micro flora,
diarrhoea and immune function, and
another study has reported better
catch-up growth in term infants with
severe  in t ra  u te r ine  growth
retardation.8
 Human mi lk  has a h igher
concentration of nucleotides than
bovine milk which is the source of
most infant formulas. As the
composition of breast milk is taken
as the “gold standard”, an increasing
number of infant formulas are
supplemented with nucleotides.
Although dietary nucleotides have
been suggested to have beneficial
gastrointestinal and immunological
effects, nucleotide-supplemented
formula feeding has not been shown
to confer the same benefits as breast
feeding. Randomised controlled trials
have yet to prove that healthy term
infants fed nucleotide-supplemented
formulas have accelerated physical
growth and neurological develop-
ment, and better growth and develop-
ment of the gastrointestinal tract.
Furthermore, it should still be proven
that they result in improved digestive
and absorptive functions, enhanced
development of their immune system
with subsequent increased resistance
to infection and lower bacterial and
viral infection rates during infancy,
and a more favourable intestinal micro
flora associated with a lower rate of
infectious diarrhoea. However, a
randomised controlled trial by Yu has
reported that term infants with severe
intrauterine growth retardation have
bet ter  catch-up growth wi th
nucleotide supplementation. The
hypothesis that nucleotides are semi-
essential nutrients needs to be further
studied, in particular in the presence
of  prematur i ty,  foeta l  growth
retardation, intestinal injury and limited
nutrient intake. As no deleterious
effects have been reported with the
use of nucleotide-supplemented
formulas, the first of which was
introduced over 30 years ago, such
products are considered safe when
nucleotides are supplemented to an
amount equivalent to the free
nucleotide concentration of human
milk.9
Conclusion
Nutrition is essential to the health and
development of infants and children.
Breastfeeding is superior to infant
formula feeding because in addition
to breast milk’s nutritional advantages,
it protects against infections through
specific and non-specific immune
fac to r s  and  has  l ong - te r m
consequences for metabolism and
disease later in life. Human milk
enhances the immature immunologic
system of the neonate and strengthens
host defence mechanisms against
infective and other foreign antigens.
Mechanisms to explain active
stimulation of the infant’s immune
system by breastfeeding are through
bioactive factors in human milk.
Following breastfeeding termination
there may be prolonged protection
against infections due to influences
on the infant immune system mediated
via human milk.10 Evidence exists to
indicate that probiotics, long chain
polyunsaturated fatty acids and
nucleotides have a critical role to play
in the development of the immune
system and its response and therefore
manufacturers attempt to imitate breast
milk by supplementing these nutrients
to ensure that non-breast-fed infants
experience these benefits.
References
1. Kelly D, Coutts AG. Early nutrition and the
development of immune function in the neonate.
Proc Nutr Soc. 2000 May; 59(2):177-185.
2. Oddy WH. The impact of breast milk on infant
and child health. Breastfeed Review. 2002 Nov;
10(3): 5-18.
3. Field CJ. The immunological components of
human milk and their effect on immune
development in infants. J Nutr. 2005 Jan; 135:1-
4.
4. Das UN. Essential fatty acids as possible
enhancers of the beneficial action of Probiotics.
Nutrition. 2002 Sep; 18(9): 786.
5. Ark International Training Seminars June 2003.
6. Sherman MP. Human milk, fatty acids, and the
immune response: a new glimpse. American
Journal of Clinical Nutrition. November 2001;
72(5):1071-1072.
7. Hawkes JS, Gibson RA. Lymphocyte
subpopulation in breast-fed and formula-fed
infants at six months of age. Adv Exp Med Biol.
2001; 501: 497-504.
8. Yu VY. Scientific rationale and benefits of
nucleotide supplementation of infant formula.
J Paediatr Child Health. 2002 Dec; 38(6):543-
549.
9. Yu VY. The role of dietary nucleotides in neonatal
and infant nutrition. Singapore Med Journal.
1998 April; 39(4): 145-150.
10. Oddy WH. Breastfeeding protects against
illness and infection in infants and children: a
review of the evidence. Breastfeed Rev. 2001
July; 9(2):11-18.
